{"id":"https://openalex.org/W2600208317","doi":null,"title":"Synthesis and biological screening of 3-chloro-2-piperazinylmethyl-N-aryl sulfonamide indole derivatives as 5-HT6 receptor ligands: Part III","display_name":"Synthesis and biological screening of 3-chloro-2-piperazinylmethyl-N-aryl sulfonamide indole derivatives as 5-HT6 receptor ligands: Part III","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2600208317","mag":"2600208317"},"language":"en","primary_location":{"id":"mag:2600208317","doi":null,"is_oa":false,"landing_page_url":"https://www.derpharmachemica.com/abstract/synthesis-and-biological-screening-of-3chloro2piperazinylmethylnaryl-sulfonamide-indole-derivatives-as-5ht6-receptor-lig-7448.html","pdf_url":null,"source":{"id":"https://openalex.org/S4306507770","display_name":"Der pharma chemica","issn_l":"0975-413X","issn":["0975-413X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharma chemica","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050284513","display_name":"Ramakrishna V. S. Nirogi","orcid":"https://orcid.org/0000-0002-2045-0784","observed_orcids":["https://orcid.org/0000-0002-2045-0784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramakrishna Nirogi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2045-0784","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035869842","display_name":"Amol D. Deshp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amol D. Deshp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023038926","display_name":"Anil K. Chindhe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil K. Chindhe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086179959","display_name":"Ramasastri Kambhampati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramasastri Kambhampati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103844324","display_name":"Anil Karbhari Shinde","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anil Shinde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028834304","display_name":"Praveen Kumar Dubey","orcid":"https://orcid.org/0000-0002-2454-4737","observed_orcids":["https://orcid.org/0000-0002-2454-4737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. K. Dubey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2454-4737","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.2309223,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"3","first_page":"909","last_page":"914"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6029999852180481,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6029999852180481,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12973","display_name":"Synthesis of Indole Derivatives","score":0.23280000686645508,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13188","display_name":"Synthesis and bioactivity of alkaloids","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/reductive-amination","display_name":"reductive amination","score":0.9909999966621399},{"id":"https://openalex.org/keywords/sulfonylation","display_name":"sulfonylation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/indole-derivatives","display_name":"indole derivatives","score":0.6579999923706055},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/heterocycle-synthesis","display_name":"heterocyclic synthesis","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C192527728","wikidata":"https://www.wikidata.org/wiki/Q1465700","display_name":"Indole test","level":2,"score":0.9262508749961853},{"id":"https://openalex.org/C2781039511","wikidata":"https://www.wikidata.org/wiki/Q3208529","display_name":"Sulfonamide","level":2,"score":0.9151233434677124},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.732459545135498},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7217998504638672},{"id":"https://openalex.org/C198503264","wikidata":"https://www.wikidata.org/wiki/Q471635","display_name":"Amination","level":3,"score":0.5029763579368591},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.46093976497650146},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.44258826971054077},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.32205918431282043},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.22905421257019043},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.12259453535079956},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2600208317","doi":null,"is_oa":false,"landing_page_url":"https://www.derpharmachemica.com/abstract/synthesis-and-biological-screening-of-3chloro2piperazinylmethylnaryl-sulfonamide-indole-derivatives-as-5ht6-receptor-lig-7448.html","pdf_url":null,"source":{"id":"https://openalex.org/S4306507770","display_name":"Der pharma chemica","issn_l":"0975-413X","issn":["0975-413X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharma chemica","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.4043000042438507,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2582818218","https://openalex.org/W2188765701","https://openalex.org/W2081662882","https://openalex.org/W2153194555","https://openalex.org/W2548101783","https://openalex.org/W2179204391","https://openalex.org/W2950815199","https://openalex.org/W2008730137","https://openalex.org/W2076554320","https://openalex.org/W1985067892"],"abstract_inverted_index":{"In":[0],"continuation":[1],"to":[2,7],"our":[3],"earlier":[4],"work":[5],"and":[6,69],"improve":[8],"upon":[9],"the":[10,44,74],"potentency":[11],"of":[12,20,34,64],"2-piperazinylmethyl-N-aryl":[13],"sulfonamide":[14,57],"indole":[15,40,58],"derivatives,":[16],"a":[17,61],"new":[18],"series":[19,63],"compounds":[21],"were":[22],"taken":[23],"up":[24],"for":[25],"synthesis":[26,68],"by":[27,53],"inserting":[28],"halo":[29],"group":[30],"at":[31],"3rd":[32],"position":[33],"indole.":[35],"The":[36,66],"critical":[37],"intermediate":[38],"3-halo-2-formyl":[39],"was":[41],"achieved":[42],"through":[43],"Vilsmerier":[45],"reaction,":[46],"which":[47],"on":[48],"further":[49],"reductive":[50],"amination":[51],"followed":[52],"sulfonylation":[54],"gave":[55],"3-chloro-2-piperazinylmethyl-N-aryl":[56],"derivatives":[59],"as":[60],"targeted":[62],"compounds.":[65],"design,":[67],"their":[70],"in-vitro":[71],"affinity":[72],"towards":[73],"5-HT6":[75],"receptor":[76],"is":[77],"discussed":[78],"in":[79],"this":[80],"communication.":[81]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}